Recursion Pharmaceuticals, Inc.(NASDAQ:RXRX) 
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rar...
Website: http://www.recursion.com
Founded: 2013
CEO: Chris Gibson
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.59
H 4.74
L 4.06
C 4.24
V 27,959,366
10EMA 4.24
20EMA 4.24
60EMA 4.24
120EMA 4.24
250EMA 4.24